Xiaoshuang Wang
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
PDL1-driven self-amplifying drug homing with immune homeostasis restoration.
Journal: Materials today. Bio
Published: May 12, 2026
Dissecting NMOSD pathogenesis through animal models: a mechanism-oriented systems perspective.
Journal: Frontiers in immunology
Published: January 22, 2026
Multimodal MRI Assessment of neuroprotective effects of Ofatumumab on brain structure, function, and clinical correlates in Relapsing Multiple Sclerosis.
Journal: Frontiers in neurology
Published: November 09, 2025
Cerebellar microstructural and functional connectivity changes in patients with neuromyelitis optica spectrum disorders and their correlation with cognitive function: a female-dominated multimodal MRI study.
Journal: Frontiers in neurology
Published: June 15, 2025
Therapeutic effects of IGF-2 on NMOSD by inhibiting astrocyte apoptosis through modulation of the IGF-1R/PI3K/AKT signaling pathway.
Journal: Scientific reports
Published: December 23, 2024
Immunoswitch Nanomodulators Enable Active Targeting and Selective Proliferation of Regulatory T Cells for Multiple Sclerosis Therapy.
Journal: ACS nano
Published: December 19, 2023
An MMAE-loaded PDL1 active targeting nanomedicine for the precision treatment of colon cancer.
Journal: Biomaterials science
Published: June 20, 2023
Lack of association between TNFA and TNFB polymorphisms and the risk of multiple sclerosis: a meta-analysis from 37 studies.
Journal: Expert review of clinical immunology
Published: August 23, 2022
Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis.
Journal: The International journal of neuroscience
Published: May 17, 2022
Immune-mediated epilepsy with GAD65 antibodies.
Journal: Journal of neuroimmunology
Published: January 11, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026